Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $34,742 | 8 | 47.6% |
| Travel and Lodging | $26,373 | 18 | 36.1% |
| Honoraria | $7,731 | 3 | 10.6% |
| Food and Beverage | $2,699 | 32 | 3.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,400 | 2 | 1.9% |
| Education | $32.27 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dexcom, Inc. | $35,234 | 24 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $20,410 | 13 | $0 (2019) |
| Novo Nordisk Inc | $7,140 | 7 | $0 (2019) |
| Eli Lilly and Company | $5,250 | 1 | $0 (2020) |
| Tandem Diabetes Care, Inc. | $2,716 | 8 | $0 (2024) |
| Insulet Corporation | $1,118 | 3 | $0 (2020) |
| Medtronic MiniMed, Inc. | $783.41 | 3 | $0 (2018) |
| Medtronic, Inc. | $174.60 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $89.23 | 2 | $0 (2019) |
| Salvin Dental Specialties, Inc. | $62.20 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,430 | 5 | Tandem Diabetes Care, Inc. ($2,256) |
| 2023 | $22,780 | 6 | Dexcom, Inc. ($22,641) |
| 2022 | $287.99 | 3 | Dexcom, Inc. ($202.66) |
| 2021 | $6,472 | 7 | DEXCOM, INC. ($6,410) |
| 2020 | $12,149 | 14 | Dexcom, Inc. ($5,695) |
| 2019 | $13,103 | 12 | SANOFI-AVENTIS U.S. LLC ($12,690) |
| 2018 | $14,921 | 13 | SANOFI-AVENTIS U.S. LLC ($7,639) |
| 2017 | $834.19 | 4 | Medtronic MiniMed, Inc. ($654.56) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Endocrinology | ||||||
| 06/23/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $71.00 | General |
| Category: Endocrinology | ||||||
| 06/22/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Durable Pump | ||||||
| 06/20/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $166.60 | General |
| Category: Durable Pump | ||||||
| 06/06/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Consulting Fee | Cash or cash equivalent | $1,434.74 | General |
| Category: Endocrinology | ||||||
| 11/17/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Consulting Fee | Cash or cash equivalent | $1,785.00 | General |
| Category: Endocrinology | ||||||
| 11/01/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Consulting Fee | Cash or cash equivalent | $2,247.25 | General |
| Category: Endocrinology | ||||||
| 09/20/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $7,266.15 | General |
| Category: Endocrinology | ||||||
| 09/20/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $2,625.20 | General |
| Category: Endocrinology | ||||||
| 08/11/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $8,717.75 | General |
| Category: Endocrinology | ||||||
| 02/22/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $139.00 | General |
| Category: Endocrinology | ||||||
| 06/05/2022 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | Cash or cash equivalent | $85.33 | General |
| Category: Endocrinology | ||||||
| 06/03/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $158.42 | General |
| Category: Endocrinology | ||||||
| 04/19/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $44.24 | General |
| Category: Endocrinology | ||||||
| 11/13/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Honoraria | Cash or cash equivalent | $2,231.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/22/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $90.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/21/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $78.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/22/2021 | Salvin Dental Specialties, Inc. | — | Food and Beverage | In-kind items and services | $62.20 | General |
| 03/16/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Travel and Lodging | Cash or cash equivalent | $3,621.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/16/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Travel and Lodging | Cash or cash equivalent | $336.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/16/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | Cash or cash equivalent | $50.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/15/2020 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| 04/23/2020 | Insulet Corporation | Omnipod (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Insulin Pump | ||||||
| 03/03/2020 | Dexcom, Inc. | DEXCOM G6 CGM SYSTEM (Device) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/21/2020 | Tandem Diabetes Care, Inc. | t:slim X2 insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $53.54 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 94 | 203 | $57,545 | $14,169 |
| 2022 | 5 | 99 | 184 | $60,485 | $15,061 |
| 2021 | 4 | 86 | 200 | $58,125 | $14,680 |
| 2020 | 3 | 58 | 112 | $44,599 | $9,303 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 65 | $27,950 | $6,643 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 35 | $20,300 | $5,583 | 27.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 18 | 50 | $8,500 | $1,498 | 17.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 53 | $795.00 | $445.20 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 72 | $30,960 | $7,757 | 25.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $13,500 | $3,259 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 17 | $9,860 | $2,905 | 29.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 15 | 33 | $5,610 | $1,030 | 18.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 37 | $555.00 | $109.47 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 94 | $40,420 | $10,881 | 26.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $9,720 | $2,286 | 23.5% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 14 | 43 | $7,310 | $1,377 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 21 | 45 | $675.00 | $135.00 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 75 | $32,250 | $6,711 | 20.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $9,180 | $1,929 | 21.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 11 | 20 | $3,169 | $663.36 | 20.9% |
About Dr. Carol Levy, MD
Dr. Carol Levy, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710074893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carol Levy, MD has received a total of $72,977 in payments from pharmaceutical and medical device companies, with $2,430 received in 2024. These payments were reported across 64 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($34,742).
As a Medicare-enrolled provider, Levy has provided services to 337 Medicare beneficiaries, totaling 699 services with total Medicare billing of $53,213. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location New York, NY
- Active Since 10/09/2006
- Last Updated 02/21/2019
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710074893
Products in Payments
- DEXCOM G7 GSS (161) (Medical Supply) $22,641
- SOTAGLIFLOZIN (Drug) $20,329
- DEXCOM G6 TRANSMITTER (Device) $6,410
- DEXCOM G6 CGM SYSTEM (Device) $5,695
- t:slim X2 Insulin Pump with Control-IQ (Device) $2,480
- Omnipod (Device) $1,118
- Enlite Sensor (Device) $654.56
- Dexcom G6 Transmitter (Medical Supply) $202.66
- DEXCOM CGM (Device) $186.67
- MINIMED 780G (Device) $174.60
- t-slim insulin pump (Device) $150.07
- Minimed 670G System (Device) $128.85
- Dexcom G5 Mobile CGM System (Device) $98.97
- JARDIANCE (Drug) $89.23
- t:slim X2 insulin pump (Device) $85.81
- DISEASE STATE (Drug) $80.66
- FIASP (Drug) $32.27
- Levemir (Drug) $29.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in New York
Dr. John Bilezikian, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $970,936
Anastasios Manessis, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $719,303
Stuart Weiss, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $520,227
Dr. Brian Levy, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $383,360
Recaredo Berbano, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $340,374
Dr. Jason Baker, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $308,409